CS
LSBPW

Clear Street’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Clear Street’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,724
Closed -$1.9K – 898
2025
Q2 		$1.9K Buy
47,724
+100
+0.2% +$4 ﹤0.01% 588
2025
Q1 		$1.96K Sell
47,624
-544
-1% -$33 ﹤0.01% 468
2024
Q4 		$3.83K Hold
48,168
– – ﹤0.01% 429
2024
Q3 		$3.18K Sell
48,168
-1,326
-3% -$84 ﹤0.01% 506
2024
Q2 		$4.36K Buy
49,494
+2,208
+5% +$181 ﹤0.01% 509
2024
Q1 		$3.39K Sell
47,286
-239
-0.5% -$13 ﹤0.01% 539
2023
Q4 		$1.81K Buy
47,525
+200
+0.4% +$7 ﹤0.01% 567
2023
Q3 		$1.95K Hold
47,325
– – ﹤0.01% 811
2023
Q2 		$2.22K Buy
47,325
+100
+0.2% +$9 ﹤0.01% 938
2023
Q1 		$7.35K Buy
+47,225
New +$7.16K ﹤0.01% 584

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Clear Street's LSBPW Position: Q3 2025 in Review

Clear Street sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 47,724 shares — an estimated $1.9K sold.

Clear Street first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $7.35K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Clear Street reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Clear Street sold 47,724 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $1.9K.
  • Clear Street first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
  • Clear Street's LakeShore Biopharma Warrants position peaked at $7.35K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Clear Street's 13F filing for Q3 2025, filed 14 Nov 2025.